EML6 Inhibitors

Chemical inhibitors of EML6 target the protein's interaction with microtubules, which are essential components of the cellular cytoskeleton. Peloruside A and Laulimalide, both also microtubule stabilizers, inhibit EML6 by altering the dynamics of the microtubule network, resulting in a stabilization that is atypical of the normal functioning state required by EML6. On the other end of the spectrum, Colchicine, Vinblastine, Nocodazole, and Podophyllotoxin act as inhibitors of microtubule polymerization. Colchicine binds to tubulin and prevents microtubule formation, thereby inhibiting EML6's ability to stabilize microtubules. Vinblastine operates in a similar manner, binding to tubulin and inhibiting microtubule assembly, which disrupts EML6's function in organizing these structures. Nocodazole's inhibition of microtubule polymerization likewise impacts EML6, preventing the normal microtubule organization that EML6 supports. Podophyllotoxin also binds to tubulin, further inhibiting the assembly of microtubules and impeding EML6's role in their stabilization.

Griseofulvin, another chemical inhibitor, disrupts microtubule function by binding to tubulin, which can inhibit EML6's ability to participate in microtubule-dependent cellular processes. Eribulin, while inhibiting the growth phase of microtubules without affecting the shortening phase, presents a unique mechanism of action that can inhibit EML6 by hindering its association with growing microtubule ends. S-Trityl-L-cysteine is another polymerization inhibitor, disrupting the microtubule network required for EML6's function. Combretastatin A4, which binds to tubulin at the colchicine site, also inhibits microtubule assembly, directly impacting the structural integrity of microtubules and thus the function of EML6. Finally, 2-Methoxyestradiol inhibits EML6 by binding to tubulin and disrupting the microtubule structures that are essential for EML6's activity within the cell.